Who
Gayle Deflin
Director
Company insider
Files Form 4 as: Director, Amphastar Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $494K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Jun 2021
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —8,143 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,365 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,365 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —8,143 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,402 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,122 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,864 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,076 at $0.00 | filing |
| 14 Nov 2023filed 15 Nov 2023 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $231K4,163 at $55.45 | filing |
| 5 Jun 2023filed 7 Jun 2023 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,016 at $0.00 | filing |
| 5 Jun 2023filed 7 Jun 2023 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —2,716 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $199K4,519 at $44.01 | filing |
| 15 May 2023filed 17 May 2023 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $65K1,500 at $43.15 | filing |
| 10 Jun 2022filed 14 Jun 2022 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,984 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,163 at $0.00 | filing |
| 7 Jun 2021filed 8 Jun 2021 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,182 at $0.00 | filing |
| 7 Jun 2021filed 8 Jun 2021 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,019 at $0.00 | filing |
News
Comparing Amphastar Pharmaceuticals (NASDAQ:AMPH) & Enanta Pharmaceuticals (NASDAQ:ENTA)AMPH · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Gayle Deflin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.